Fresh analysis indicates that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight far faster than those who stop traditional lifestyle regimens.
Research printed in a leading health publication shows that while obese people frequently drop about a fifth of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.
"People using such treatments must be aware of the risk of rapid weight regain when the therapy is stopped," warns expert Dr. Susan Jebb.
This pace of recovery means a reversion to starting mass in about 18 months.
Weighing Treatments
The study, which looked at 37 of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who lose weight through lifestyle changes alone usually have a less rapid weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Nutrition scientists believe the mechanism of the drugs is key to understanding the amplified rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating much more probable."
An Ongoing Disease?
Health authorities advise the injections for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, due to the likelihood of weight regain, the therapy should be considered long-term.
This perspective is echoed by drug manufacturers, who state that the findings "emphasize the persistent character of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
People who have stopped the jabs report a powerful return of appetite.
"It felt as if something flipping and I was suddenly starving," recalled one woman.
The struggle is worsened if users have not adopted lasting lifestyle or habit changes during therapy.
Widespread Interest
Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Use is more common among women than males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a standalone fix and lasting health benefits likely depends on ongoing lifestyle changes.
